Literature DB >> 7768335

Vasoactive intestinal peptide gene expression in the rat pheochromocytoma cell line PC12.

T Tsukada1, M Fukushima, H Takebe, Y Nakai.   

Abstract

Vasoactive intestinal peptide (VIP) gene expression was analyzed in PC12 cells. VIP mRNA was detected in PC12 cells treated with VIP or forskolin whereas no VIP mRNA was detected in the untreated cells. The induction of the VIP mRNA was enhanced by the simultaneous treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA). PC12 cells stimulated with forskolin plus TPA released immunoreactive VIP. Sephadex G-50 column chromatography revealed that the immunoreactive VIP secreted from PC12 cells is comprised of multiple forms, one of which was indistinguishable from the authentic VIP. PC12 cells supported an efficient transcription from the human VIP gene promoter in a cell-specific as well as cAMP-dependent manner. These results definitely demonstrated the expression of the VIP gene in PC12 cells. VIP biosynthesis may be positively regulated by VIP in an autocrine fashion in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768335     DOI: 10.1016/0303-7207(94)03448-3

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress.

Authors:  R A Steingart; B Solomon; D E Brenneman; M Fridkin; I Gozes
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

2.  Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.

Authors:  R P Mohney; R E Zigmond
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

3.  Enhancement of catecholamine release from PC12 cells by the traditional Japanese medicine, rikkunshito.

Authors:  Yuko Nagamura; Kiyoshi Terawaki; Yasuhito Uezono; Toshihiko Tsukada
Journal:  BMC Complement Altern Med       Date:  2014-07-19       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.